Accelerating clinical trials with AI endpoints.
Toronto
Joined July 2020
- Tweets81
- Following244
- Followers109
- Likes56
Altis Labs retweeted
OrbiMed investing outside of life sciences/medtech into application layer AI/@altislabs is a statement. This company must be doing something special.
We’re pleased to co-lead @altislabs' $25 million Series A and support the team as they work to improve the measurement of treatment efficacy in clinical trials. As our Partner Tal Zaks noted, better early efficacy signals can help drug developers make more informed decisions about which therapies to advance.
altislabs.com/news/altis-lab…
Altis Labs retweeted
Our portco @altislabs raised $25M in #SeriesA funding to bring #AI endpoints into #OncologyTrials. Its flagship model, #IPRO, uses routine scans to predict survival and detect treatment effects earlier, helping drug developers learn what works sooner. Congrats @FelixBL92 & team!
Altis Labs retweeted
We’re pleased to co-lead @altislabs' $25 million Series A and support the team as they work to improve the measurement of treatment efficacy in clinical trials. As our Partner Tal Zaks noted, better early efficacy signals can help drug developers make more informed decisions about which therapies to advance.
altislabs.com/news/altis-lab…
Altis Labs retweeted
"There is risk in not acting". Engaging discussions on #AI and #HealthData at #CTOConf2024! This morning’s panel is diving into how data-driven tools are reshaping #clinicaltrials for better precision and outcomes.
Altis Labs retweeted
The @altislabs team is excited to announce that two abstracts have been accepted at @myESMO for poster presentation this year, illustrating our latest research with biopharma partners and research collaborators.
Please reach out if you're headed to Barcelona for #ESMO24 this September, we would love to connect!
Altis Labs retweeted
Excited to be back in NYC next week for the AI x Bio Summit!
Programming note: BiotechTV will be broadcasting from the AI x Bio Summit at @NYSE on Thursday, July 25th. Tune in to hear from top companies and investors in the space.
Altis Labs retweeted
Join me on Wednesday for a discussion about Digital Twins in oncology trials here in Toronto at #MaRSImpactHealth, Canada's largest healthcare conference.
The panel will include our partners at @BayerPharma and will be moderated by science journalist @AyeshaR1202.
When: Wednesday, 2:20pm ET
Where: @MaRSDD, Toronto
Register here: impacthealth.marsdd.com/
Altis Labs retweeted
Find out how Toronto-based @altislabs is transforming the future of clinical trials and healthcare with AI.
statnews.com/2024/04/03/ai-b…
Altis Labs retweeted
Biopharma companies are beginning to turn to AI to enroll people in clinical trials. trib.al/0R11vzW
Altis Labs retweeted
Fantastic article by @ADeAngelis_bio on how our team at @altislabs is using AI to transform clinical trials – thank you for the shoutout!
If sponsors focus too heavily on reductionist tumor size measurements to guesstimate efficacy, “they might be pushing a drug into late-stage development that’s not going to improve survival, or deprioritize a drug that would have been a blockbuster and would have significantly improved outcomes.”
Startups are using AI to pinpoint which people are more likely to respond to a treatment or potentially even create surrogate trial participants known as digital twins. trib.al/AfgUQ31
Altis Labs retweeted
Excellent article by @ZacharyBrennan at @endpts on how @US_FDA is "increasingly calling for more robust overall survival data that can prove treatments help patients live longer."
endpts.com/fda-pushes-cancer…
Altis Labs retweeted
Big news for the ecosystem! @altislabs is launching their Digital Twin AI models with @AstraZeneca and @BayerPharma, accelerating clinical trials and increasing reliability.
Congratulations to the entire team!🎉
Read more: ow.ly/e0aG50PCRWx
We are thrilled to announce the launch of our Digital Twin AI models with @AstraZeneca & @BayerPharma.
Read about how we are speeding up clinical trials and reducing failure rates in bringing novel, efficacious cancer treatments to patients in need. einpresswire.com/article/651…
Altis Labs retweeted
Thank you @FierceBiotech for covering our product launch!
#ai #clinicaltrials #digitaltwins #deeplearning #nsclc
fiercebiotech.com/cro/altis-…
Altis Labs retweeted
Today, @altislabs announced that they are leading an international🌍coalition focused on the development and implementation of #digitaltwins in clinical trials. Congratulations to the entire team on their huge achievement!🎊
Read the press release here: einpresswire.com/article/651…
Altis Labs retweeted
Altis Labs Raises US $6 Million in Seed Funding Co-Led by Debiopharm and Benchstrength to Advance AI Platform for Clinical Trials @altislabs @DebiopharmNews @benchstrengthr #healthIT
healthcareittoday.com/?p=230…
Altis Labs retweeted
Altis Labs Raises US $6 Million in Seed Funding Co-Led by Debiopharm and Benchstrength to Advance AI Platform for Clinical Trials #HITsm @altislabs @DebiopharmNews @benchstrengthr
healthcareittoday.com/?p=230…
Altis Labs retweeted
Altis Labs Raises US $6 Million in Seed Funding Co-Led by Debiopharm and Benchstrength to Advance AI Platform for Clinical Trials #hcldr @altislabs @DebiopharmNews @benchstrengthr
healthcareittoday.com/?p=230…
Altis Labs retweeted
.@Altislabs (CDL'20), which helps biopharmaceutical companies analyze medical imaging and expedite clinical trials using AI, has secured $7.9M CAD in seed funding. #BuildSomethingMassive
betakit.com/altis-labs-close…
Altis Labs retweeted
Toronto-based @altislabs, which helps biopharma firms analyze medical imaging and expedite clinical trials using #AI, has secured $7.9 million CAD in seed funding. #CDNtech betakit.com/altis-labs-close…
Altis Labs retweeted
Congrats to @altislabs on this partnership that will fuel the development of their #AI-powered #imaging biomarker platform, accelerating treatments with improved efficiency while transforming the #healthcare landscape. #lifesciences #innovation
Excited to announce our US $6M funding. Thrilled to have Benchstrength and @Debiopharm join us on our mission to reduce the excessive time and cost it takes to bring novel, effective treatments to patients in need.
businesswire.com/news/home/2…
